1st Circ. Crushes Objection To $24M Zoladex Deal

Law360, New York (November 20, 2009, 6:41 PM EST) -- A federal appeals court panel has upheld a $24 million settlement in a class action that accused AstraZeneca Pharmaceuticals LP of artificially inflating prices for the prostate cancer drug Zoladex.

One unhappy named plaintiff, M. Joyce Howe, had challenged the settlement in the U.S. Court of Appeals for the First Circuit, saying all recovery should be distributed to class members rather than having some go into a cy pres fund for charity.

She also argued that the settlement was improperly negotiated, that its method for calculating...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.